Olaf‐Oliver Wolz

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

Peter G. Kremsner, Philipp Mann, Arne Kroidl et al. · Wiener klinische Wochenschrift · 2021 · 132 citations · Full text

Veterinary Medicine, Immunology, Molecular Pharmaceutics +17

Human NACHT, LRR, and PYD domain–containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase

Xiao Liu, Tica Pichulik, Olaf‐Oliver Wolz et al. · Journal of Allergy and Clinical Immunology · 2017 · 130 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

B-cell–specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice

Gero Knittel, Paul Liedgens, Darya Korovkina et al. · Blood · 2016 · 111 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size

Katharina Fuchs, Yamel Cardona Gloria, Olaf‐Oliver Wolz et al. · EMBO Reports · 2018 · 110 citations · Full text

Life Sciences, Immunology, Microbiology +12

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

Peter G. Kremsner, Philipp Mann, Jacobus J. Bosch et al. · medRxiv · 2020 · 103 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17